PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - van Laar, Jacob M.
TI  - The ASTIS Trial: First Results
DP  - 2012 Sep 01
TA  - MD Conference Express
PG  - 8--8
VI  - 12
IP  - 9
4099  - http://mdc.sagepub.com/content/12/9/8.1.short
4100  - http://mdc.sagepub.com/content/12/9/8.1.full
AB  - This article discusses the first results from the Autologous Stem Cell Transplantation International Scleroderma trial [ASTIS; ISRCTN54371254], an international, investigator-initiated, open-label Phase 3 trial that suggests that hematopoietic stem cell transplantation results in better long-term event-free and overall survival compared with conventional treatment for patients with poor prognosis, early diffuse, cutaneous systemic sclerosis.